Literature DB >> 21659869

Pharmacology of peripheral opioid receptors.

Banafscheh Rachinger-Adam1, Peter Conzen, Shahnaz C Azad.   

Abstract

PURPOSE OF REVIEW: Since the detection of morphine by the pharmacologist Friedrich Sertürner in 1806, opioids have been used as potent centrally acting analgesics. In addition to the central site of action, peripheral endogenous opioid analgesic systems have been extensively studied, especially in the past two decades. This review is not only mentioned to give a brief summary in this well investigated field of peripheral opioid receptors, but also to highlight the role of peripheral opioid receptors in other physiological and pathophysiological conditions. RECENT
FINDINGS: A number of studies, which initially focused on nociception, also revealed an important role of the peripheral opioid receptor system in opioid-induced bowel dysfunction and pruritus, as well as in wound healing, cardioprotection, and the analgesic effects of celecoxib.
SUMMARY: Efforts continue to develop opioid analgesics unable to cross the blood-brain barrier, which act only peripherally in low doses, thus providing adequate analgesia without central and systemic side-effects.The awareness of the influence of peripheral opioid receptors beyond nociception may also have therapeutic ramifications on the other fields mentioned above. For example, the treatment of opioid-induced bowel dysfunction by methylnaltrexone is one of the major findings in the previous years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659869     DOI: 10.1097/ACO.0b013e32834873e5

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  10 in total

Review 1.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.

Authors:  Charl Els; Tanya D Jackson; Diane Kunyk; Vernon G Lappi; Barend Sonnenberg; Reidar Hagtvedt; Sangita Sharma; Fariba Kolahdooz; Sebastian Straube
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

Review 2.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 3.  Basic concepts in opioid prescribing and current concepts of opioid-mediated effects on driving.

Authors:  Adam M Kaye; Alan D Kaye; Elise C Lofton
Journal:  Ochsner J       Date:  2013

4.  The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.

Authors:  Mihály Balogh; Zoltán S Zádori; Bernadette Lázár; Dávid Karádi; Szilvia László; Shaaban A Mousa; Sándor Hosztafi; Ferenc Zádor; Pál Riba; Michael Schäfer; Susanna Fürst; Mahmoud Al-Khrasani
Journal:  Neurochem Res       Date:  2018-05-03       Impact factor: 3.996

Review 5.  Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.

Authors:  Stefan Müller-Lissner; Gabrio Bassotti; Benoit Coffin; Asbjørn Mohr Drewes; Harald Breivik; Elon Eisenberg; Anton Emmanuel; Françoise Laroche; Winfried Meissner; Bart Morlion
Journal:  Pain Med       Date:  2017-10-01       Impact factor: 3.750

6.  To evaluate the Efficacy of Buprenorphine and 2% lignocaine with adrenaline as postoperative analgesia following mandibular third molar surgery: A Comparative Study.

Authors:  Sachin Prakash Bagade; Sanjay S Joshi; Sneha Punamiya; Anuradha Malliwal; Charudatta S Naik; Arsalan Ansari
Journal:  Ann Maxillofac Surg       Date:  2022-02-01

Review 7.  Effect of Fentanyl as an Adjuvant to Brachial Plexus Block for Upper Extremity Surgeries: A Systematic Review and Meta-Analysis of RCTs.

Authors:  Liangsong Song; Shulian Tan; Qingmin Chen; He Li
Journal:  Pain Res Manag       Date:  2022-03-19       Impact factor: 3.037

8.  Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation.

Authors:  Nada Charbaji; Monika Schäfer-Korting; Sarah Küchler
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

9.  A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.

Authors:  M Mazen Jamal; Atoya B Adams; Jan-Peter Jansen; Lynn R Webster
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

Review 10.  Evolution of nociception and pain: evidence from fish models.

Authors:  Lynne U Sneddon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.